Veeva Systems Gathers Biopharma Leaders to Chart AI-Driven Commercial Strategies

Event summary

  • Veeva Systems hosts its Commercial Summit in Boston on May 19-20, 2026, featuring leaders from 15+ biopharma companies.
  • Over 100 sessions will focus on AI-driven commercial strategies, including next-generation CRM and agentic content strategies.
  • More than 2,000 industry professionals and 40 sponsoring partners are expected to attend.
  • Key topics include precision data powering AI, medical insights driving patient outcomes, and DTC launch strategies.

The big picture

Veeva Systems is positioning itself as a central player in the AI-driven transformation of biopharma commercial strategies. The summit highlights the industry's shift towards agentic commercial models, where AI, data, and industry-specific applications converge to enhance engagement and operational efficiency. With over 1,500 customers ranging from top 20 biopharmas to emerging biotechs, Veeva's role in shaping the future of commercial engagement in life sciences is significant.

What we're watching

AI Integration
How Veeva's AI-driven solutions will scale across biopharma companies to improve commercial engagement and patient outcomes.
Data Precision
Whether the integration of deep data by companies like Merck and Takeda will sustain long-term AI-driven business processes.
Regulatory Compliance
The pace at which Boehringer Ingelheim and Gilead can deliver instant, compliant answers to doctors and patients while maintaining data security.